You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 7,745,571


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,745,571
Title:Peptide inhibitors of IASPP
Abstract: The invention relates to a polypeptide or part thereof which inhibits the apoptotic activity of the tumor suppressor protein p53, and includes screening methods to identify agents which interfere with the activity of the polypeptide.
Inventor(s): Lu; Xin (London, GB), Kuwabara; Patricia (Bristol, GB), Selwood; David (London, GB)
Assignee: Ludwig Institute for Cancer Research (New York, NY) Genome Research Limited (Cambridge, GB) UCL Cruciform Limited (Long, GB)
Application Number:12/043,058
Patent Claims:1. An isolated peptide consisting of an amino acid sequence selected from the group consisting of: DGPEETD (SEQ ID NO: 2); GPEETD (SEQ ID NO: 1); TTLSDG (SEQ ID NO: 3); AEFGDE (SEQ ID NO: 8, amino acids 294-299); or PRNYFG (SEQ ID NO: 4).

2. An isolated peptide that is 6-20 amino acids in length and that comprises the sequence AEFGDE (SEQ ID NO: 8, positions 294-299), wherein the isolated peptide is capable of inhibiting iASPP binding to p53.

3. An isolated peptide consisting of: (a) an amino acid sequence selected from the group consisting of: DGPEETD (SEQ ID NO: 2); GPEETD (SEQ ID NO: 1); TTLSDG (SEQ ID NO: 3); AEFGDE (SEQ ID NO: 8, amino acids 294-299); or PRNYFG (SEQ ID NO: 4); and (b) an arginine tag.

4. A composition comprising the peptide according to claim 1 and a carrier, diluent, or excipient.

5. A composition comprising at least one peptide according to claim 1 or claim 2 and at least one anti-cancer agent.

6. The composition according to claim 5 wherein said anticancer agent is selected from the group consisting of: cisplatin; carboplatin; cyclosphosphamide; melphalan; carmusline; methotrexate; 5-fluorouracil; cytarabine; mercaptopurine; daunorubicin; doxorubicin; epirubicin; vinblastine; vincristine; dactinomycin; mitomycin C; taxol; L-asparaginase; G-CSF; etoposide; colchicine; derferoxamine mesylate; and camptothecin.

7. The composition according to claim 6 wherein said anticancer agent is cisplatin.

8. The composition according to claim 6 wherein said anticancer agent is doxorubicin.

9. A complex comprising the peptide according to claim 1 or claim 2 and an antibody, or antigen-binding domain thereof.

10. The complex according to claim 9 wherein said antibody or antigen binding domain is a cell-specific antibody.

11. The complex according to claim 9 wherein said antibody is a cancer cell-specific antibody.

12. An isolated peptide consisting of amino acids AEFGDE (SEQ ID NO: 8, amino acids 294-299) attached to an arginine tag.

13. A composition comprising the peptide according to claim 12 and at least one anti-cancer agent.

14. A complex comprising the peptide according to claim 12 and an antibody or antigen-binding domain thereof.

15. The peptide of claim 2, wherein the peptide includes an arginine tag.

16. The peptide of claim 15, wherein the arginine tag contains 2-10 residues.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.